Tirofiban

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2069 publications

Ticagrelor-Aspirin With Thrombolysis by Infarct Patterns in Moderate Ischemic Stroke: TAPIS Subgroup Analysis.

Ticagrelor-Aspirin With Thrombolysis by Infarct Patterns in Moderate Ischemic Stroke: TAPIS Subgroup Analysis.

Journal: Stroke
Published: September 03, 2026

Tirofiban for Branch Atheromatous Disease-Related Stroke: The STRATEGY Randomized Clinical Trial.

Tirofiban for Branch Atheromatous Disease-Related Stroke: The STRATEGY Randomized Clinical Trial.

Journal: JAMA neurology
Published: August 31, 2026

In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d.

In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d.

Journal: Annals of internal medicine
Published: August 31, 2026

Tirofiban for Branch Atheromatous Disease-End of the Line or New Opportunity?

Tirofiban for Branch Atheromatous Disease-End of the Line or New Opportunity?

Journal: JAMA neurology
Published: August 31, 2026

Tirofiban-Associated Thrombocytopenia: A Case Report.

Tirofiban-Associated Thrombocytopenia: A Case Report.

Journal: Cureus
Published: July 15, 2026

Tirofiban Versus Alteplase for Patients With Minor Acute Ischemic Stroke: A Target Trial Emulation Study.

Tirofiban Versus Alteplase for Patients With Minor Acute Ischemic Stroke: A Target Trial Emulation Study.

Journal: Journal of the American Heart Association
Published: July 10, 2026

Delayed M1 Dissection After Thrombectomy Treated With Rescue Stenting and Tirofiban: A Case Report.

Delayed M1 Dissection After Thrombectomy Treated With Rescue Stenting and Tirofiban: A Case Report.

Journal: Cureus
Published: July 01, 2026

Impact of tirofiban on outcomes in STEMI patients across different levels of inflammation: a stratified analysis based on complete blood count-derived inflammatory markers

Impact of tirofiban on outcomes in STEMI patients across different levels of inflammation: a stratified analysis based on complete blood count-derived inflammatory markers

Journal: Zhonghua xin xue guan bing za zhi
Published: June 21, 2026

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial.

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR): A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial.

Journal: Stroke
Published: June 12, 2026

Tirofiban and thrombectomy for acute ischaemic stroke.

Tirofiban and thrombectomy for acute ischaemic stroke.

Journal: Lancet (London, England)
Published: June 10, 2026

Real-world comparison of tirofiban versus aspirin in acute non-large-vessel occlusion ischemic stroke: A retrospective cohort study.

Real-world comparison of tirofiban versus aspirin in acute non-large-vessel occlusion ischemic stroke: A retrospective cohort study.

Journal: Pakistan journal of pharmaceutical sciences
Published: June 09, 2026

Intravenous tirofiban in non-LVO progressive stroke beyond the thrombolysis window.

Intravenous tirofiban in non-LVO progressive stroke beyond the thrombolysis window.

Journal: Pakistan journal of pharmaceutical sciences
Published: June 09, 2026
Showing 1-12 of 2,069

Last Updated: 09/26/2026